Protective Effects of Demethylbellidifolin on Myocardial Ischemia-Reperfusion Injury in Rats

Abstract

The effect of demethylbellidifolin (DMB), a major compound of Swertia davidi Franch, on ischemia-reperfusion injury was studied in rats. Ischemia-reperfusion injury in vivo and in vitro was induced by 20 min of global ischemia followed 40 min of reperfusion and 60 min of coronary artery occlusion followed 180 min of reperfusion, respectively. DMB (100 or 300 μg/L) significantly improved the recovery of cardiac function during reperfusion in isolated rat hearts, as shown by enhancement of coronary flow, left ventricular pressure and its first derivatives (±dp/dt_max). DMB decreased the release of creatine kinase in coronary effluent as well as the level of malondialdehyde in myocardial tissues. In vivo, DMB (0.5 or 1.0 mg/kg) markedly decreased infarct size and the release of creatine kinase. These results suggest that DMB protects the myocardium against damage due to ischemia-reperfusion in rats. The present study also suggests that the effect of DMB may be related to inhibition of lipid peroxidation.

Key words

Demethylbellidifolin - Swertia davidi - Gentianaceae - ischemia-reperfusion - heart - rat

References

• 1 Peres V, Nagem T J, de Oliveira F F. Tetraoxygenated naturally occurring xanthones.  Phytochemistry. 2000;  55 683-710
• 2 Gonda R, Takeda T, Akiyama T. Studies on the constituents of Anaxagorea luzonensis. A. GRAY. Chem Pharm Bull (Tokyo); 2000 48: 1219-22
• 3 Minami H, Takahashi E, Fukuyama Y, Kodama M, Yoshizawa T, Nakagawa K. Novel xanthones with superoxide scavenging activity from Garcinia subelliptica . Chem pharm Bull (Tokyo); 1995 43: 347-9
• 4 Mahabusarakam W, Proudfoot J, Taylor W,Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin.  Free Radic Res. 2000;  33 643-59
• 5 Chang C H, Lin C C, Hattori M, Namba T. Effects on anti-lipid peroxidation of Cudrania cochinchinensis var. gerontogea .  J Ethnopharmcol. 1994;  44 79-85
• 6 Koerner J E, Anderson B A, Dage R C. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: superoxide dismutase plus catalase, N-2-mercaptopropionylglycine and captopril.  J Cardiovasc Pharm. 1991;  17 85-91
• 7 Kloner R A, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.  Circulation. 1989;  80 1115-27
• 8 Hong C Y, Huang S S, Tsai S K. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation.  Clin Exp Pharmacol Physiol. 1996;  23 660-4
• 9 Huang C H, Hong C Y, Tsai S K, Lai S T, Weng Z C, Chih C L, Hsieh Y H. Intravenous pretreatment with magnolol protects myocardium against stunning.  Planta Med. 2000;  66 516-20
• 10 Carini M, Aldini G, Rossoni G, Morazzoni P, Facino R M. Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increases the plasma antioxidant capacity in the rat.  Planta Med. 2001;  67 326-30
• 11 Haramaki N, Aggarwal S, Kawabata T, Droy-Lefaix M T, Packer L. Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury.  Free Radic Bio Med. 1994;  16 789-94
• 12 Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.  Anal Biochem. 1979;  95 351-8
• 13 Goldhaber J I, Weiss J N. Oxygen free radicals and cardiac reperfusion abnormalities.  Hypertension. 1992;  20 118-27
• 14 Dhalla N S, Golfman L, Takeda S, Takeda N, Nagano M. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review.  Can J Cardiol. 1999;  15 587-93